Results 101 to 110 of about 226,540 (179)

Oral dissolution therapy for renal radiolucent stones, outcome, and factors affecting response: A prospective study

Urology Annals, 2019
Background: Urolithiasis is a widespread problem, that affects up to 10% of population. Uric acid stones come second to calcium stones in prevalence (around 10% of urolithiasis).
Shady Mohammed Salem, Mohammed Farag Sultan, Atef Badawy   +2 more
doaj   +1 more source

Formulation and examination of a new urine alkalizing tablet for the symptomatic treatment of bladder pain syndrome

Journal of Drug Delivery Science and Technology, 2022
Adrienn Horváth, Gábor Vasvári, Sándor Lovász, Györgyi Horváth, Péter Birinyi   +4 more
openaire   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside

International Journal of Nephrology and Renovascular Disease, 2022
Viola D’Ambrosio,1,2 Pietro Manuel Ferraro1,2 1U.O.S. Terapia Conservativa della Malattia Renale Cronica, U.O.C. Nefrologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia; 2Dipartimento
D'Ambrosio V, Ferraro PM
doaj  

Urinary Alkalization Therapy in Primary Gout: A Narrative Review

Gout is a systemic metabolic inflammatory disease driven by hyperuricemia and monosodium urate crystal deposition, and is frequently accompanied by chronic kidney disease and uric acid nephrolithiasis.
Changgui Li, Mingshu Sun, Chuantao Wu, Xianghong Meng, Rui Wang   +4 more
core   +1 more source

Urine-derived epithelial cell lines: a new tool to model fragile X syndrome (FXS)

, 2020
Fragile X syndrome (FXS) is an X-linked neurodevelopmental condition associated with intellectual disability and behavioral problems due to the lack of the Fragile X mental retardation protein (FMRP), which plays a crucial role in synaptic plasticity and
M Jasoliya (10091626), Flora Tassone (9483407), M Zafarullah (9972692)   +2 more
core   +1 more source

Trastuzumab Deruxtecan‐Induced Myotoxicity: First Case Report About Myopathy in Patient With Normal Body Composition and Clinical Insights

Thoracic Cancer
Trastuzumab deruxtecan (T‐DXd) significantly improves outcomes in HER2‐positive or low metastatic breast cancer (MBC), but systematic documentation of its myotoxicity is lacking. A 45‐year‐old woman with HER2‐low MBC and normal body composition (BMI 22.9 
Zhen Qiao, LiuDan Li, Hong Wang, ShuHui Dai, LiTong Ye   +4 more
doaj   +1 more source

Effects of Adding Urinary Alkalizer Citrate Mixture to Febuxostat in Gout Patients with Combined-type Hyperuricemia and Acidic Urine: A Prospective Cohort Study

Abstract Background People with gout and combined-type hyperuricemia, defined as renal urate overload and renal urate under-excretion, have diminished responsiveness to urate-lowering therapy. Emerging observational data suggest that urine alkalization might improve responsiveness to febuxostat.
Kai Guo, Changgui Li, Robert Terkeltaub, Nicola Dalbeth, Xuefeng Wang, Xiaopeng Ji, Ying Chen, Lingling Cui, Zhen Liu, Xinde Li, Yuwei He, Jie Lu, Wenyan Sun, Lin Han, Hui Zhang, Aichang Ji, Mingshu Sun, Can Wang   +17 more
openaire   +1 more source

Corrigendum: Effects of alkalization therapy on hepatocellular carcinoma: a retrospective study

Frontiers in Oncology, 2023
Masahide Isowa, Reo Hamaguchi, Ryoko Narui, Hiromasa Morikawa, Hiromi Wada   +4 more
doaj   +1 more source

Voltammetric behaviour of p-nitrophenol and its trace determination in human urine by liquid chromatography with a dual reductive mode electrochemical detection system

, 2007
The determination of trace p-nitrophenol (PNP) concentrations in human urine has been successfully achieved by high performance liquid chromatography dual electrode detection (LC-DED) in the reduction-reduction mode.
Hart, John P., Kevin C. Honeychurch, John P. Hart, Honeychurch, Kevin C.   +3 more
core   +1 more source